12:00 AM
 | 
Jul 13, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Panflu pandemic Influenza vaccine regulatory update

China's State Food and Drug Administration (SFDA) approved a revised drug supplementary application to expand the label of Panflu H1N1 pandemic influenza vaccine to include...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >